Metabolic dysfunction-associated steatotic liver disease (MASLD) is now considered to be among the most prevalent chronic liver diseases worldwide. Its comprehensive management encompasses multiple stages, including risk assessment, early detection, stratified intervention, and long-term follow-up. Among these, improving diagnostic accuracy and optimizing individualized therapeutic strategies remain key challenges in both research and clinical practice. In recent years, artificial intelligence and smart devices have developed rapidly and have gradually been applied in the medical field, offering novel tools and pathways for MASLD risk stratification, non-invasive diagnosis, therapeutic evaluation, and patient self-management. This review summarizes the current applications of artificial intelligence and smart devices in MASLD care, highlights their benefits and limitations, and discusses future directions to support precision diagnosis and treatment strategies.

New research reveals that by 10 months old, infants are already beginning to understand verbs, before they even say their first words.The study, from the University of East Anglia and Cardiff University, is the first to test infants' understanding of verbs using brain imaging technology. The team measured brain rhythms to visualise babies’ understanding of these word classes. And they found that by 10 months, babies could detect inconsistencies between actions and the verbs describing them.